NasdaqCM - Delayed Quote USD

Tempest Therapeutics, Inc. (TPST)

7.11
-0.36
(-4.82%)
At close: June 12 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
44,988
42,026
29,157
34,640
26,986
Operating Income
-44,988
-42,026
-29,157
-34,640
-26,986
Net Non Operating Interest Income Expense
189
183
-334
-1,018
-1,275
Other Income Expense
--
--
15
-51
-41
Pretax Income
-44,799
-41,843
-29,491
-35,709
-28,302
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-44,799
-41,843
-29,491
-35,709
-28,302
Diluted NI Available to Com Stockholders
-44,799
-41,843
-29,491
-35,709
-28,302
Basic EPS
-18.04
-19.50
-24.83
-40.17
-97.11
Diluted EPS
-18.04
-19.50
-24.83
-40.17
-97.11
Basic Average Shares
2,578.12
2,146.29
1,185.86
888.95
291.56
Diluted Average Shares
2,578.12
2,146.29
1,185.86
888.95
291.56
Total Operating Income as Reported
-44,988
-42,026
-29,157
-34,640
-26,986
Total Expenses
44,988
42,026
29,157
34,640
26,986
Net Income from Continuing & Discontinued Operation
-44,799
-41,843
-29,491
-35,709
-28,302
Normalized Income
-44,799
-41,843
-29,491
-35,709
-28,302
Interest Income
1,298
1,499
1,115
600
7
Interest Expense
1,109
1,316
1,449
1,618
1,282
Net Interest Income
189
183
-334
-1,018
-1,275
EBIT
-43,690
-40,527
-28,042
-34,091
-27,020
EBITDA
-43,321
-40,138
-27,661
-33,453
-26,646
Reconciled Depreciation
369
389
381
638
374
Net Income from Continuing Operation Net Minority Interest
-44,799
-41,843
-29,491
-35,709
-28,302
Normalized EBITDA
-43,321
-40,138
-27,661
-33,453
-26,646
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/12/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KZIA Kazia Therapeutics Limited
9.79
+2.62%
 
EYEN Eyenovia, Inc.
2.6700
-20.77%
 
SNPX Synaptogenix, Inc.
4.8600
-4.52%
 
EVGN Evogene Ltd.
1.5200
-16.02%
 
PYPD PolyPid Ltd.
3.4300
-0.87%
 
WINT Windtree Therapeutics, Inc.
0.6040
-13.69%
 
LIMN Liminatus Pharma, Inc.
20.31
+82.81%
 
ELAB PMGC Holdings Inc.
2.1700
-0.91%
 
NCNA NuCana plc
0.1520
-7.88%
 
CTXR Citius Pharmaceuticals, Inc.
0.9200
-8.91%